Olive Sensing

Olive Sensing

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Olive Sensing is pioneering the digitization of home healthcare with its passive toilet-mounted urinalysis sensor, the Olive KG. The device combines advanced optics, IoT, and AI to provide continuous, real-time analysis of urine biomarkers, shifting diagnostics from episodic to continuous monitoring. The company targets the growing market for remote patient monitoring and preventive care, with a vision to make urine a key data source for proactive health management. Its success hinges on clinical validation, regulatory clearance, and consumer adoption of its novel hardware-software platform.

Diagnostics

Technology Platform

Toilet-mounted optical sensor combining IoT connectivity and AI analytics for passive, real-time urinalysis.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The company operates in the high-growth remote patient monitoring and preventive health markets, driven by an aging population and a shift to decentralized care.
Its passive data collection offers a unique value proposition for managing chronic diseases like diabetes and kidney conditions, potentially reducing overall healthcare costs through early intervention.

Risk Factors

Key risks include the unproven clinical accuracy of its novel optical sensing technology, significant regulatory hurdles for FDA clearance as a medical device, and the consumer adoption challenge of installing a health sensor in a private bathroom.
Data privacy and security are also major concerns.

Competitive Landscape

Olive Sensing appears to be first-to-market with a fully passive, toilet-mounted urinalysis sensor. Competition exists from traditional home urinalysis dipsticks, emerging smart toilet technologies from academic research, and broader remote monitoring platforms from large medtech and digital health companies that may expand into this niche.